SSY Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:2005 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Apr 24BuyHK$4,675,199China Pharmaceutical Company LimitedCompany1,000,000HK$4.68
17 Apr 24BuyHK$3,810,403China Pharmaceutical Company LimitedCompany800,000HK$4.76
05 Apr 24BuyHK$2,523,165China Pharmaceutical Company LimitedCompany524,000HK$4.82
03 Apr 24BuyHK$7,513,495Jiguang QuIndividual1,500,000HK$5.01
02 Apr 24BuyHK$10,244,200China Pharmaceutical Company LimitedCompany2,000,000HK$5.12
28 Mar 24BuyHK$2,451,850Jiguang QuIndividual500,000HK$4.90
14 Dec 23BuyHK$7,394,103China Pharmaceutical Company LimitedCompany1,500,000HK$4.93
08 Dec 23BuyHK$2,129,042China Pharmaceutical Company LimitedCompany450,000HK$4.73
07 Dec 23BuyHK$3,289,488China Pharmaceutical Company LimitedCompany694,000HK$4.74
05 Dec 23BuyHK$4,741,002Jiguang QuIndividual1,000,000HK$4.74
04 Dec 23BuyHK$4,795,901China Pharmaceutical Company LimitedCompany1,000,000HK$4.80
24 Nov 23BuyHK$2,976,719China Pharmaceutical Company LimitedCompany600,000HK$4.96
03 Nov 23BuyHK$2,193,099China Pharmaceutical Company LimitedCompany500,000HK$4.39
31 Oct 23BuyHK$4,339,803China Pharmaceutical Company LimitedCompany1,000,000HK$4.34
05 Oct 23BuyHK$2,187,598China Pharmaceutical Company LimitedCompany500,000HK$4.38
03 Oct 23BuyHK$2,251,499China Pharmaceutical Company LimitedCompany500,000HK$4.50
29 Sep 23BuyHK$4,466,997China Pharmaceutical Company LimitedCompany1,000,000HK$4.47
28 Sep 23BuyHK$4,591,102China Pharmaceutical Company LimitedCompany1,000,000HK$4.59
07 Sep 23BuyHK$1,274,669China Pharmaceutical Company LimitedCompany300,000HK$4.25
05 Sep 23BuyHK$1,338,390China Pharmaceutical Company LimitedCompany300,000HK$4.46
11 Jul 23BuyHK$1,699,411Jiguang QuIndividual370,000HK$4.59
07 Jul 23BuyHK$8,333,693Jiguang QuIndividual1,892,000HK$4.40
06 Jul 23BuyHK$4,460,100China Pharmaceutical Company LimitedCompany1,000,000HK$4.46
05 Jul 23BuyHK$4,801,999China Pharmaceutical Company LimitedCompany1,000,000HK$4.80
23 Jun 23BuyHK$3,208,268China Pharmaceutical Company LimitedCompany650,000HK$4.94
31 May 23BuyHK$2,850,780China Pharmaceutical Company LimitedCompany600,000HK$4.75
09 May 23BuyHK$4,938,201Jiguang QuIndividual1,000,000HK$4.94
09 May 23BuyHK$5,021,499China Pharmaceutical Company LimitedCompany1,000,000HK$5.02
05 May 23BuyHK$5,236,696China Pharmaceutical Company LimitedCompany1,000,000HK$5.24
26 Apr 23BuyHK$2,755,551China Pharmaceutical Company LimitedCompany500,000HK$5.51

Insider Trading Volume

Insider Buying: 2005 insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2005?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders309,424,00010.4%
Institutions567,298,24519.1%
General Public652,901,14022%
Private Companies1,439,420,00048.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 77.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
28.1%
China Pharmaceutical Company Limited
832,698,000HK$3.9b0.52%no data
20.4%
Sichuan Kelun Industry Group CO., LTD.
606,722,000HK$2.8b0%no data
9.95%
UBS Asset Management AG
295,537,657HK$1.4b-3.28%0.03%
9.6%
Jiguang Qu
285,008,000HK$1.3b0.71%no data
1.84%
The Vanguard Group, Inc.
54,608,554HK$256.1m0.18%no data
1.06%
Dimensional Fund Advisors LP
31,493,164HK$147.7m0.24%no data
0.82%
Xuejun Su
24,416,000HK$114.5m0%no data
0.75%
BlackRock, Inc.
22,378,375HK$105.0m-1.24%no data
0.75%
Norges Bank Investment Management
22,219,268HK$104.2m20.7%no data
0.71%
UBS SDIC Fund Management Co., Ltd.
21,060,000HK$98.8m0%0.28%
0.55%
Bosera Asset Management Co., Ltd.
16,218,000HK$76.1m0%0.06%
0.43%
Wanjia Asset Management Co., Ltd.
12,826,000HK$60.2m0%0.11%
0.42%
Penghua Fund Management Co., Ltd.
12,618,000HK$59.2m849%0.05%
0.42%
Nordea Investment Management, AB
12,349,823HK$57.9m-0.06%0.01%
0.3%
Fullgoal Fund Management Co. Ltd.
8,906,000HK$41.8m0%0.02%
0.23%
GF Fund Management Co., Ltd.
6,850,000HK$32.1m0%0.01%
0.21%
Australian Super Pty Ltd
6,218,000HK$29.2m0%no data
0.19%
China Universal Asset Management Company Ltd.
5,604,000HK$26.3m0%0.01%
0.14%
American Century Investment Management Inc
4,209,991HK$19.7m10.7%no data
0.13%
China Asset Management Co. Ltd.
3,952,324HK$18.5m-0.9%no data
0.12%
ICBC Credit Suisse Asset Management Co., Ltd.
3,448,000HK$16.2m0%0.01%
0.1%
Principal Global Investors, LLC
3,026,625HK$14.2m0%no data
0.095%
State Street Global Advisors, Inc.
2,814,763HK$13.2m-2.96%no data
0.074%
Invesco Great Wall Fund Management Co. Ltd
2,200,000HK$10.3m0%0.01%
0.073%
Storebrand Fonder AB,
2,178,000HK$10.2m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.